Trials / Completed
CompletedNCT05473975
Search for a Recanalization of the Sylvian Artery Electro-Physiological Biomarker
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Early recanalization is a major prognostic factor in vascular accidents ischemic brain injury (AIC). The acute phase therapies of AIC aim to recanalization by intravenous thrombolysis and/or mechanical thrombectomy. Recanalization is identified immediately during thrombectomy by per-procedural arteriography. For the thrombolysis, only a performed MRI will validate the recanalization. This "proof of concept" study aims to identify an Electro-Encephalographic biomarker (EEG) of the recanalization in real time, the EEG being easy to set up. This biomarker will be sought during recanalization certified by thrombectomy in order to identify the window time for which the biomarker must be sought on the EEG. During this study, the identified EEG biomarker can be used to validate the recanalization during the intravenous thrombolysis in future studies
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Placement of the EGG | Placement of the EGG before the beginning of the thrombectomy |
Timeline
- Start date
- 2023-01-24
- Primary completion
- 2025-01-23
- Completion
- 2025-01-23
- First posted
- 2022-07-26
- Last updated
- 2025-06-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05473975. Inclusion in this directory is not an endorsement.